Individuals Stopping Slimming Injections Regain Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

A recent study reveals that individuals who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise regimens.

Findings released in a major health publication demonstrates that while obese individuals often shed substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month after stopping.

"People buying such medications need to be cognizant of the risk of fast rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.

That rate of recovery means a reversion to original mass within about a year and a half.

Analyzing Therapies

The study, which examined 37 of studies involving over 9,000 of patients, compared the outcomes of these new drugs with older methods.

The team note that people who lose weight through dieting usually experience a slower creep back—around 100 grams monthly—after stopping.

Understanding the Rapid Regain

Doctors propose the mechanism of the jabs accounts for the accelerated regain.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Long-term administration of the hormone concentrations far above than normal might result in the body to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making overeating a significant risk."

An Ongoing Issue?

Medical guidelines advise the jabs for people with weight-linked medical conditions, alongside prescribed lifestyle changes.

Professionals contend that, due to the high risk of relapse, the therapy is often ongoing.

This opinion is echoed by drug manufacturers, who state that the results "emphasize the chronic nature of obesity," akin to managing diseases like hypertension.

Patient Accounts

Users who have stopped the medication report a powerful return of cravings.

"It felt as if something flipping and I was suddenly ravenous," recalled a patient.

The struggle is compounded if users have not established sustainable dietary or behavioural modifications during therapy.

Growing Interest

Figures show that millions of adults in the UK have tried these injections in the past year, with interest being substantial.

• Use is greater among females compared to males.
• The middle-aged age group shows the greatest usage rates.
• Many obtain the medications through private prescriptions rather than the NHS.

Ultimately, experts stress that while these medications are potent tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on combined lifestyle management.